Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 03-Mar-14 4:15 PM View:  | de Silva Rajiv President & CEO Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 63,315 | -- | -- | (25%) 255.07K to 191.76K | |
| 03-Mar-14 4:27 PM View: | Hyatt Michael Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 234,228 | -- | -- | (88%) 265.74K to 31.52K | |
| 03-Mar-14 4:36 PM View: | Spengler William Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 69,177 | -- | -- | (100%) 69.18K to 0 | |
| 03-Mar-14 4:28 PM View: | Kimmel Roger H Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 227,862 | -- | -- | (100%) 227.86K to 0 | |
| 03-Mar-14 4:17 PM View: | Degolyer Donald W Chief Operating Officer,Pharma | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 76,571 | -- | -- | (100%) 76.57K to 0 | |
| 03-Mar-14 4:23 PM View: | Higgins Arthur J Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 1,016 | -- | -- | (100%) 1.02K to 0 | |
| 03-Mar-14 4:30 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 138,800 | -- | -- | (100%) 138.8K to 0 | |
| 03-Mar-14 4:32 PM View: | Montague William P Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 27,393 | -- | -- | (100%) 27.39K to 0 | |
| 03-Mar-14 4:19 PM View: | Delucca John Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 28,111 | -- | -- | (100%) 28.11K to 0 | |
| 03-Mar-14 4:34 PM View: | Smith Jill D. Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 9,599 | -- | -- | (100%) 9.6K to 0 | |
| 03-Mar-14 4:15 PM View: | de Silva Rajiv President & CEO Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 191,758 | -- | -- | (100%) 191.76K to 0 | |
| 03-Mar-14 4:27 PM View: | Hyatt Michael Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 25,000 | -- | -- | (79%) 31.52K to 6.51K | |
| 03-Mar-14 4:33 PM View: | Rudio Daniel Vice President, Controller | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 6,949 | -- | -- | (100%) 6.95K to 0 | |
| 03-Mar-14 4:15 PM View: | de Silva Rajiv President & CEO Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 164,921 | -- | -- | (39%) 419.99K to 255.07K | |
| 03-Mar-14 4:25 PM View: | Hutson Nancy J Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 26,998 | -- | -- | (100%) 27.0K to 0 | |
| 03-Mar-14 4:27 PM View: | Hyatt Michael Director | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 6,515 | -- | -- | (100%) 6.51K to 0 | |
| 03-Mar-14 4:11 PM View: | Gergel Ivan EVP, R&D and CSO | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 81,763 | -- | -- | (100%) 81.76K to 0 | |
| 03-Mar-14 4:38 PM View: | Upadhyay Suketu EVP, Chief Financial Officer | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 46,056 | -- | -- | (100%) 46.06K to 0 | |
| 03-Mar-14 4:21 PM View: | Farhat Camille President, AMS, Inc. | Endo Pharmaceuticals Holdin... (ENDP) | 28-Feb-14 | Disposition | 51,602 | -- | -- | (100%) 51.6K to 0 | |
| 28-Feb-14 4:24 PM View: | Gergel Ivan EVP, R&D and CSO | Endo Pharmaceuticals Holdin... (ENDP) | 27-Feb-14 | Payment of Exercise | 909 | $79.82 | $72,556.40 | (3%) 28.56K to 27.65K | 87% |
| 28-Feb-14 4:21 PM View: | Farhat Camille President, AMS, Inc. | Endo Pharmaceuticals Holdin... (ENDP) | 27-Feb-14 | Payment of Exercise | 239 | $79.82 | $19,077.00 | (< 1%) 43.79K to 43.55K | 87% |
| 28-Feb-14 4:30 PM View: | Rudio Daniel Vice President, Controller | Endo Pharmaceuticals Holdin... (ENDP) | 27-Feb-14 | Payment of Exercise | 251 | $79.82 | $20,034.80 | (3%) 7.88K to 7.63K | 87% |
| 28-Feb-14 4:27 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 27-Feb-14 | Payment of Exercise | 1,009 | $79.82 | $80,538.40 | (< 1%) 141.79K to 140.78K | 87% |
| 28-Feb-14 4:30 PM View: | Rudio Daniel Vice President, Controller | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-14 | Grant | 1,604 | -- | -- | 26% 6.28K to 7.88K | |
| 28-Feb-14 4:24 PM View: | Gergel Ivan EVP, R&D and CSO | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-14 | Payment of Exercise | 9,105 | $78.30 | $712,922.00 | (26%) 35.67K to 26.56K | 87% |
| 28-Feb-14 4:24 PM View: | Gergel Ivan EVP, R&D and CSO | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-14 | Grant | 6,658 | -- | -- | 23% 29.01K to 35.67K | |
| 28-Feb-14 4:32 PM View: | Upadhyay Suketu EVP, Chief Financial Officer | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-14 | Grant | 15,220 | -- | -- | 49% 30.84K to 46.06K | |
| 28-Feb-14 4:21 PM View: | Farhat Camille President, AMS, Inc. | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-14 | Grant | 16,248 | -- | -- | 59% 27.54K to 43.79K | |
| 28-Feb-14 4:27 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-14 | Payment of Exercise | 8,973 | $78.30 | $702,586.00 | (6%) 148.78K to 139.81K | 87% |
| 28-Feb-14 4:16 PM View: | Degolyer Donald W Chief Operating Officer,Pharma | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-14 | Grant | 15,363 | -- | -- | 25% 61.21K to 76.57K | |
| 28-Feb-14 4:27 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 26-Feb-14 | Grant | 20,210 | -- | -- | 16% 128.57K to 148.78K | |
| 25-Feb-14 4:10 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 23-Feb-14 | Payment of Exercise | 1,495 | $77.26 | $115,504.00 | (3%) 57.3K to 55.8K | 86% |
| 25-Feb-14 4:18 PM View: | Rudio Daniel Vice President, Controller | Endo Pharmaceuticals Holdin... (ENDP) | 23-Feb-14 | Payment of Exercise | 132 | $77.26 | $10,198.30 | (7%) 1.78K to 1.65K | 86% |
| 25-Feb-14 4:04 PM View: | Gergel Ivan EVP, R&D and CSO | Endo Pharmaceuticals Holdin... (ENDP) | 23-Feb-14 | Payment of Exercise | 1,517 | $77.26 | $117,203.00 | (9%) 17.21K to 15.7K | 86% |
| 25-Feb-14 4:18 PM View: | Rudio Daniel Vice President, Controller | Endo Pharmaceuticals Holdin... (ENDP) | 22-Feb-14 | Payment of Exercise | 193 | $77.26 | $14,911.20 | (12%) 1.66K to 1.46K | 86% |
| 25-Feb-14 4:04 PM View: | Gergel Ivan EVP, R&D and CSO | Endo Pharmaceuticals Holdin... (ENDP) | 22-Feb-14 | Payment of Exercise | 1,531 | $77.26 | $118,285.00 | (10%) 15.41K to 13.88K | 86% |
| 25-Feb-14 4:10 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 22-Feb-14 | Payment of Exercise | 1,653 | $77.26 | $127,711.00 | (3%) 56.02K to 54.36K | 86% |
| 21-Feb-14 4:02 PM View: | Gergel Ivan EVP, R&D and CSO | Endo Pharmaceuticals Holdin... (ENDP) | 19-Feb-14 | Payment of Exercise | 10,127 | $75.22 | $761,753.00 | (46%) 22.18K to 12.05K | 86% |
| 21-Feb-14 4:16 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 19-Feb-14 | Payment of Exercise | 6,656 | $75.22 | $500,664.00 | (11%) 59.43K to 52.77K | 86% |
| 21-Feb-14 4:24 PM View: | Rudio Daniel Vice President, Controller | Endo Pharmaceuticals Holdin... (ENDP) | 19-Feb-14 | Payment of Exercise | 207 | $75.22 | $15,570.50 | (15%) 1.42K to 1.21K | 86% |
| 02-Jan-14 8:38 PM View: | de Silva Rajiv President & CEO Director | Endo Pharmaceuticals Holdin... (ENDP) | 31-Dec-13 | Payment of Exercise | 7,179 | $67.29 | $483,075.00 | (4%) 172.1K to 164.92K | 84% |
| 02-Jan-14 8:40 PM View: | Nash David Director | Endo Pharmaceuticals Holdin... (ENDP) | 31-Dec-13 | Grant | 222 | -- | -- | 2% 11.64K to 11.86K | |
| 02-Jan-14 8:39 PM View: | Kimmel Roger H Director | Endo Pharmaceuticals Holdin... (ENDP) | 31-Dec-13 | Grant | 778 | -- | -- | 1% 53.07K to 53.85K | |
| 02-Oct-13 4:11 PM View: | Nash David Director | Endo Pharmaceuticals Holdin... (ENDP) | 30-Sep-13 | Grant | 330 | -- | -- | 3% 11.31K to 11.64K | |
| 02-Oct-13 4:10 PM View: | Kimmel Roger H Director | Endo Pharmaceuticals Holdin... (ENDP) | 30-Sep-13 | Grant | 1,155 | -- | -- | 2% 51.91K to 53.07K | |
| 09-Sep-13 5:34 PM View: | Farhat Camille President, AMS, Inc. | Endo Pharmaceuticals Holdin... (ENDP) | 05-Sep-13 | Payment of Exercise | 1,789 | $43.00 | $76,927.00 | (34%) 5.33K to 3.54K | 75% |
| 27-Aug-13 5:18 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 26-Aug-13 | Option Exercise | 130,000 | $28.61 | $3,719,300.00 | 210% 62.01K to 192.01K | |
| 27-Aug-13 5:18 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 26-Aug-13 | Market Option Sale | 130,000 | $39.40 | $5,122,000.00 | (68%) 192.01K to 62.01K | 73% |
| 27-Aug-13 5:18 PM View: | Manogue Caroline B Exec. V.P., CLO & Secy | Endo Pharmaceuticals Holdin... (ENDP) | 26-Aug-13 | Market Sale | 15,592 | $39.40 | $614,325.00 | (25%) 62.01K to 46.42K | 73% |
| 09-Aug-13 5:13 PM View: | Kimmel Roger H Director | Endo Pharmaceuticals Holdin... (ENDP) | 08-Aug-13 | Market Purchase | 5,478 | $36.50 | $199,947.00 | 12% 46.44K to 51.91K | (71%) |
